Wintac Ltd. gets 84.17% of its revenue from
Formulations
Wintac Limited
Market Cap:
₹0 Cr.
Percentage Revenue:
10.31%
Formulations
Wintac Limited
Market Cap:
₹0 Cr.
Percentage Revenue:
84.17%
Formulations
Bajaj Healthcare Limited
Market Cap:
₹0 Cr.
Percentage Revenue:
2.33%
Formulations
Bal Pharma Limited
Market Cap:
₹76 Cr.
Percentage Revenue:
58.59%
Formulations
Vivimed Labs Limited
Market Cap:
₹136 Cr.
Percentage Revenue:
14%
Formulations
Kopran Limited
Market Cap:
₹513 Cr.
Percentage Revenue:
99.5%
Formulations
RPG Life Sciences Limited
Market Cap:
₹702 Cr.
Percentage Revenue:
41.03%
Formulations
RPG Life Sciences Limited
Market Cap:
₹702 Cr.
Percentage Revenue:
58.97%
Formulations
RPG Life Sciences Limited
Market Cap:
₹702 Cr.
Percentage Revenue:
20.18%
Formulations
RPG Life Sciences Limited
Market Cap:
₹702 Cr.
Percentage Revenue:
59.34%
Formulations
Panacea Biotec Limited
Market Cap:
₹1,209 Cr.
Percentage Revenue:
78.94%
Formulations
Morepen Laboratories Limited
Market Cap:
₹1,248 Cr.
Percentage Revenue:
21.7%
Formulations
Unichem Laboratories Limited
Market Cap:
₹2,069 Cr.
Percentage Revenue:
90%
Formulations
Indoco Remedies Limited
Market Cap:
₹2,868 Cr.
Percentage Revenue:
86.71%
Formulations
Shilpa Medicare Limited
Market Cap:
₹3,436 Cr.
Percentage Revenue:
24.16%
Formulations
Caplin Point Laboratories Limited
Market Cap:
₹3,576 Cr.
Percentage Revenue:
100%
Formulations
FDC Limited
Market Cap:
₹5,133 Cr.
Percentage Revenue:
91.31%
Formulations
Sequent Scientific Limited
Market Cap:
₹5,364 Cr.
Percentage Revenue:
65%
Formulations
Aarti Drugs Limited
Market Cap:
₹6,687 Cr.
Percentage Revenue:
11%
Formulations
JB Chemicals & Pharmaceuticals Limited
Market Cap:
₹8,087 Cr.
Percentage Revenue:
41.78%
Formulations
JB Chemicals & Pharmaceuticals Limited
Market Cap:
₹8,087 Cr.
Percentage Revenue:
37.89%
Formulations
Glenmark Pharmaceuticals Limited
Market Cap:
₹13,863 Cr.
Percentage Revenue:
%
Formulations
Jubilant Life Sciences Limited
Market Cap:
₹14,152 Cr.
Percentage Revenue:
11.19%
Formulations
Natco Pharma Limited
Market Cap:
₹16,293 Cr.
Percentage Revenue:
54.47%
Formulations
Natco Pharma Limited
Market Cap:
₹16,293 Cr.
Percentage Revenue:
77.05%
Formulations
Alembic Pharmaceuticals Limited
Market Cap:
₹18,880 Cr.
Percentage Revenue:
85%
Formulations
IPCA Laboratories Limited
Market Cap:
₹25,128 Cr.
Percentage Revenue:
20.48%
Formulations
IPCA Laboratories Limited
Market Cap:
₹25,128 Cr.
Percentage Revenue:
53.98%
Formulations
Torrent Pharmaceuticals Limited
Market Cap:
₹44,602 Cr.
Percentage Revenue:
20.71%
Formulations
Torrent Pharmaceuticals Limited
Market Cap:
₹44,602 Cr.
Percentage Revenue:
42.15%
Formulations
Biocon Limited
Market Cap:
₹45,924 Cr.
Percentage Revenue:
11.9%
Formulations
Biocon Limited
Market Cap:
₹45,924 Cr.
Percentage Revenue:
32.07%
Formulations
Cadila Healthcare Limited
Market Cap:
₹47,793 Cr.
Percentage Revenue:
6%
Formulations
Cadila Healthcare Limited
Market Cap:
₹47,793 Cr.
Percentage Revenue:
12%
Formulations
Cadila Healthcare Limited
Market Cap:
₹47,793 Cr.
Percentage Revenue:
26%
Formulations
Cadila Healthcare Limited
Market Cap:
₹47,793 Cr.
Percentage Revenue:
44%
Formulations
Lupin Limited
Market Cap:
₹49,072 Cr.
Percentage Revenue:
12%
Formulations
Lupin Limited
Market Cap:
₹49,072 Cr.
Percentage Revenue:
45%
Formulations
Aurobindo Pharma Limited
Market Cap:
₹58,477 Cr.
Percentage Revenue:
87%
Formulations
Divi's Laboratories Limited
Market Cap:
₹94,794 Cr.
Percentage Revenue:
49%
Formulations
Sun Pharmaceuticals Industries Limited
Market Cap:
₹140,733 Cr.
Percentage Revenue:
30%
Formulations
Sun Pharmaceuticals Industries Limited
Market Cap:
₹140,733 Cr.
Percentage Revenue:
33%